Public company
Retension Pharmaceuticals, Inc.
RTSNCIK 0002002988
Price$12.21
1 year+15.9%
Disclosed transactions1
Buys / sells0 / 0
Max Insider Score9
Connections with evidence2
RTSN · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Wong RobertVP, Chief Accounting Officer | RTSNRetension Pharmaceuticals, Inc. Grant or award | A | — 25.0K sh | Nov 4, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
- ← Insider ofevidenceWong RobertVP, Chief Accounting Officer · Nov 4, 2026